Published in New England Journal of Medicine · View the paper (DOI)
A new study found that high levels of soluble urokinase plasminogen activator receptor (suPAR) in the blood predict patients at increased risk of acute kidney injury. The protein may be a promising target for future therapies or interventions to prevent or treat AKI.
Coverage from 2 institutions